S. aureus, enterotoxins ID'd in atopic keratoconjunctivitis

April 24, 2012
S. aureus enterotoxins ID'd in atopic keratoconjunctivitis

(HealthDay) -- Staphylococcus aureus (S. aureus) and S. aureus-secreted enterotoxins (SE) are frequently found in patients with atopic keratoconjunctivitis (AKC), particularly in those with corneal ulceration, according to a study published online April 10 in Allergy.

Hiroshi Fujishima, M.D., from the Tsurumi University School of in Yokohama, Japan, and colleagues enrolled 18 individuals with AKC, nine with vernal keratoconjunctivitis (VKC), eight with seasonal allergic (SAC), and 10 healthy volunteers to investigate the role of SE in the pathophysiology of AKC. Participants underwent slit lamp examinations, including fluorescein staining. Samples were collected from the skin around the eyelid margins, lower conjunctival sacs, and upper tarsal conjunctiva. Superantigen (SAg) genes were identified using assays.

The researchers found that, compared with VKC patients, SAC patients, and healthy volunteers, S. aureus was detected significantly more in AKC patients. In 11 patients, SAg genes were identified and included SEB (two of 11), SEG (eight of 11), and SEI (eight of 11). SE detection varied significantly between AKC and SAC patients. SE was detected in significantly more patients with corneal ulcers (six of 10) than in patients without corneal ulcers (two of 17).

"S. aureus and SE were frequently found in association with corneal ulceration, suggesting a pathogenic role in the development of ulcers in AKC," the authors conclude.

Explore further: Steroids could help heal some corneal ulcers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Steroids could help heal some corneal ulcers

October 18, 2011
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be ...

Long-term use of antibiotic to treat acne not associated with increased bacterial resistance

April 11, 2011
The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS. aureus bacteria and was not associated with increased resistance to the tetracycline antibiotics, ...

Low levels of resistant bacteria found in Chicago-area ambulances

March 29, 2012
Treatment areas of ambulances fared well when tested for dangerous bacteria, according to a new study published in the April issue of the American Journal of Infection Control, the official publication of APIC - the Association ...

Recommended for you

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

Asthma researchers test substance from coralberry leaves

September 14, 2017
The coralberry could offer new hope for asthmatics. Researchers at the University of Bonn have extracted an active pharmaceutical ingredient from its leaves to combat asthma, a widespread respiratory disease. In mice, it ...

Respiratory experts urge rethink of 'outdated' asthma categorisation

September 12, 2017
A group of respiratory medicine experts have called for an overhaul of how asthma and other airways diseases are categorised and treated.

New 'biologic' drug may help severe asthma

September 7, 2017
(HealthDay)—A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.

Songbird study shows how estrogen may stop infection-induced brain inflammation

August 31, 2017
The chemical best-known as a female reproductive hormone—estrogen—could help fight off neurodegenerative conditions and diseases in the future. Now, new research by American University neuroscience Professor Colin Saldanha ...

New insights into protein's role in inflammatory response

July 28, 2017
A protein called POP2 inhibits a key inflammatory pathway, calming the body's inflammatory response before it can become destructive, Northwestern Medicine scientists have demonstrated in mouse models.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.